Rite Aid completes its sale of Elixir
PHILADELPHIA — Rite Aid Corporation has completed the previously announced sale of its Elixir Solutions business to MedImpact Healthcare Systems for approximately $576.5 million. “We are pleased to finalize the sale of Elixir, marking another important milestone in our transformation to strengthen our long-term financial position,” said Jeffrey Stein, Rite Aid’s CEO and chief restructuring